Novartis | Credores Comerciais



Trade Creditors Alterar Data
AbbVie 2.94B 2.66B 2024-12
Alcon AG USD 773M 76M 2024-12
Almirall EUR 182.33M 88.28M 2024-06
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.54B 79M 2025-03
Autolus Therapeutics Ltd 1.97M 551K 2024-12
Bayer EUR 7.52B 957M 2024-12
Biogen USD 424.2M 1.5M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Eli Lilly USD 3.23B 342.1M 2024-12
Fresenius EUR 1.36B 139M 2024-12
Fresenius Medical Care EUR 904M 132M 2024-12
Galapagos EUR 168.94M 70.06M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
GRIFOLS EUR 852.3M 25.42M 2024-12
Hikma Pharmaceutical USD 541M 232M 2024-06
J&J USD 10.31B 1.36B 2024-12
Lonza CHF 468M 9M 2023-12
Merck EUR 1.5B 448M 2024-12
Merck USD 4.08B 493M 2024-12
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Novo Nordisk 24.08B 5.68B 2024-09
Orion EUR 89.7M 2.6M 2025-03
Pfizer USD 5.63B 319M 2024-12
Philips EUR 1.83B 20M 2024-12
Recordati EUR 276.91M 13.26M 2024-09
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
UCB 750M 1.66B 2024-12



Novartis Credores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.